Raymond Myers analyst

Currently out of the existing stock ratings of Raymond Myers, 7 are a BUY (70%), 3 are a HOLD (30%).

Raymond Myers

Work Performance Price Targets & Ratings Chart

Analyst Raymond Myers, carries an average stock price target met ratio of 100% that have a potential upside of 29.49% achieved within 211 days. Previously, Raymond Myers worked at BENCHMARK.

Raymond Myers’s has documented 24 price targets and ratings displayed on 4 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on HSKA, Heska at 07-May-2018.

Wall Street Analyst Raymond Myers

Analyst best performing recommendations are on EXAS (EXACT SCIENCES).
The best stock recommendation documented was for EXAS (EXACT SCIENCES) at 10/31/2017. The price target of $60 was fulfilled within 7 days with a profit of $5.01 (9.11%) receiving and performance score of 13.02.

Average potential price target upside

EXAS EXACT Sciences HSKA Heska LMAT LeMaitre Vascular NVTA Invitae Corp

Analyst name

Rating

Rating initiation date

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

Since 09-Jul-2021

$105

$3.26 (3.20%)

$75

1 months 15 days ago
(25-Nov-2025)

9/13 (69.23%)

$3.87 (3.83%)

406

Buy

Since 31-May-2013

$105

$3.26 (3.20%)

$85

1 months 16 days ago
(24-Nov-2025)

21/24 (87.5%)

$3.99 (3.95%)

203

Buy

Since 02-Jan-2024

$75

1 months 16 days ago
(24-Nov-2025)

14/14 (100%)

$8.02 (11.97%)

205

Buy

Since 23-Jan-2025

$105

$3.26 (3.20%)

$77

1 months 19 days ago
(21-Nov-2025)

8/9 (88.89%)

$4.1 (4.06%)

126

Buy

Since 10-Oct-2023

$80

$-21.74 (-21.37%)

$70

1 months 29 days ago
(11-Nov-2025)

13/13 (100%)

$12.5 (18.52%)

284

Show more analysts

Please expand the browser size to see the chart

What Year was the first public recommendation made by Raymond Myers?

On 2015

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?